Serum Levels of Gelatinase Associated Lipocalin as Indicator of the Inflammatory Status in Coronary Artery Disease
Table 2
Median and range of serum, urine NGAL, hs-CRP serum creatinine, and eGFR(MDRD) among patient groups and healthy controls.
Nr
Stable angina
Unstable Angina
NSTEMI
STEMI
Control group
Units
40
35
40
25
20
hs-CRP median (quartiles)
mg/dL
0.40 (0.05–0.87)
0.69 (0.11–3.69)
1.17 (0.24–13.21)
3.91 (0.31–13.62)
0.12 (0.02–0.25)
WBC count, mean (SD)
(×103)
7.67 (1.99)
9.38 (2.32)
11.50 (2.65)
14.67 (4.92)
nd
Neutrophil count, mean (SD)
(×103)
4.90 (1.72)
6.44 (1.96)
8.27 (2.44)
11.08 (4.15)
nd
s-NGAL () median (quartiles)
ng/mL
79.23 (37.50–100.32)
108.00 (68.34–177.59)
166.49 (109.24–247.20)
178.63 (111.18–305.92)
50.31 (44.30–69.78)
s-Creatinine, mean (SD)
μmol/L
79.72 (16.94)
79.86 (17.78)
86.04 (21.74)
88.65 (34.46)
81.26 (7.97)
eGFR(MDRD), mean (SD)
mL/min
89.71 (19.85)
89.63 (22.96)
85.79 (22.20)
81.75 (21.06)
97.65 (19.55)
() for the comparison between patients with SA and controls, for the comparison between patients with SA with patients with UA, and for the comparisons of rest groups, and = NS for the comparison of patients with STEMI with NSTEMI.
